biOasis Technologies receives patent for blood-brain barrier tech; Medical marijuana co. plans drug discovery platform;

> biOasis Technologies announced a U.S. patent covering "the delivery of therapeutic agents by using polypeptides from the company's Transcend BBB (blood-brain barrier) delivery vector." More

> Medical marijuana company CannaPharmaRx announced plans for its CannaSyn technology to rapid, targeted new molecule discovery and production. More

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.